- Home
- TLRY
TLRY
Tilray Brands Inc.
as 12-17-2024 4:00pm EST
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 1.5B | IPO Year: | 2018 |
| Target Price: | $1.88 | AVG Volume (30 days): | 29.0M |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.27 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.15 - $2.97 | Next Earning Date: | 01-07-2025 |
| Revenue: | $812,037,000 | Revenue Growth: | 24.76% |
| Revenue Growth (this year): | 17.01% | Revenue Growth (next year): | 5.96% |
Latest Tilray Brands Inc. News
TLRY Breaking Stock News: Dive into TLRY Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
Is Tilray Brands (TLRY) Among the Best Cannabis Stocks To Invest In?
Zacks
5 days ago
Tilray Brands Introduces Herb & Bloom Non-Alcoholic Beverage
GlobeNewswire
6 days ago
Unwrap the Ultimate Holiday Experience with Good Supply’s Flavour-Packed Innovations
GlobeNewswire
6 days ago
Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC Beverages
Zacks
7 days ago
Tilray Brands, Inc. (TLRY) Stock Dips While Market Gains: Key Facts
GlobeNewswire
7 days ago
Tilray Canada Launches THC Beverage Holiday Campaign Featuring XMG and Mollo Brands for Festive Season Celebrations
Insider Monkey
8 days ago
Why Tilray Brands (TLRY) Is the Best Beer Stock to Buy Now?
Zacks
14 days ago
Tilray Brands, Inc. (TLRY) Stock Slides as Market Rises: Facts to Know Before You Trade
Compare TLRY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TLRY Tilray Brands Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.